US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.602
  • +0.072+1.59%
Trading Jan 23 10:24 ET
498.59MMarket Cap-2.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics (ACRS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-24.91%95.91M
-10.16%99.81M
-17.83%105.31M
-4.63%113.59M
-4.63%113.59M
23.94%127.72M
-7.25%111.09M
-24.96%128.17M
-45.26%119.11M
-45.26%119.11M
-Cash and cash equivalents
-47.00%25.26M
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-38.39%24.57M
22.06%47.65M
-26.70%22.83M
-19.86%35.84M
-11.92%39.88M
-11.92%39.88M
-Short-term investments
-11.76%70.66M
-15.70%74.4M
-18.81%74.96M
12.36%89.02M
12.36%89.02M
25.09%80.07M
-0.41%88.26M
-26.77%92.33M
-54.02%79.23M
-54.02%79.23M
Receivables
1,264.43%4.68M
-40.31%194K
-32.98%250K
6.71%318K
6.71%318K
-0.87%343K
-24.59%325K
-45.63%373K
-38.43%298K
-38.43%298K
-Accounts receivable
1,264.43%4.68M
-40.31%194K
-32.98%250K
6.71%318K
6.71%318K
-0.87%343K
-24.59%325K
-45.63%373K
-38.43%298K
-38.43%298K
Other current assets
----
-32.41%4.2M
-52.55%3.23M
27.37%12.04M
27.37%12.04M
-78.32%4.27M
-51.16%6.22M
-47.18%6.8M
-29.96%9.45M
-29.96%9.45M
Total current assets
-23.98%100.59M
-11.42%104.2M
-19.62%108.79M
-2.25%125.95M
-2.25%125.95M
7.53%132.33M
-11.51%117.64M
-26.59%135.34M
-44.35%128.86M
-44.35%128.86M
Non current assets
Net PPE
-28.42%811K
-32.87%868K
-38.47%942K
-37.78%1.01M
-37.78%1.01M
-35.77%1.13M
-31.91%1.29M
1.19%1.53M
47.41%1.62M
47.41%1.62M
-Gross PPE
-0.31%5.8M
1.12%5.88M
-0.24%5.86M
0.54%5.81M
0.54%5.81M
-8.72%5.81M
-7.85%5.81M
2.55%5.87M
12.62%5.78M
12.62%5.78M
-Accumulated depreciation
-6.50%-4.98M
-10.84%-5.01M
-13.25%-4.91M
-15.45%-4.81M
-15.45%-4.81M
-1.65%-4.68M
-2.52%-4.52M
-3.04%-4.34M
-3.15%-4.16M
-3.15%-4.16M
Investments and advances
55.96%71.3M
109.10%81.08M
156.67%85.21M
43.86%90.3M
43.86%90.3M
-45.54%45.71M
-57.38%38.78M
-1.20%33.2M
412.75%62.77M
412.75%62.77M
Other non current assets
-11.91%2.83M
-11.05%2.99M
-21.17%3.15M
-26.26%3.07M
-26.26%3.07M
20.89%3.22M
16.52%3.37M
22.05%4M
52.20%4.16M
52.20%4.16M
Total non current assets
49.69%74.94M
95.56%84.95M
130.60%89.3M
37.68%94.38M
37.68%94.38M
-47.46%50.06M
-57.71%43.44M
-14.59%38.73M
197.44%68.55M
197.44%68.55M
Total assets
-3.76%175.53M
17.43%189.15M
13.80%198.09M
11.61%220.33M
11.61%220.33M
-16.47%182.39M
-31.65%161.07M
-24.22%174.07M
-22.46%197.41M
-22.46%197.41M
Liabilities
Current liabilities
Payables
19.90%9.19M
21.02%8.8M
-41.22%6.35M
-47.17%4.69M
-47.17%4.69M
-20.58%7.66M
-36.38%7.27M
31.99%10.81M
-14.23%8.88M
-14.23%8.88M
-accounts payable
19.90%9.19M
21.02%8.8M
-41.22%6.35M
-47.17%4.69M
-47.17%4.69M
-20.58%7.66M
-36.38%7.27M
31.99%10.81M
-14.23%8.88M
-14.23%8.88M
Current accrued expenses
72.53%3.66M
-10.18%3.26M
-23.12%3.75M
-26.45%11.43M
-26.45%11.43M
-79.21%2.12M
-25.11%3.62M
5.23%4.87M
356.14%15.54M
356.14%15.54M
Current deferred liabilities
67.25%6.3M
--9.33M
--6.98M
--7.82M
--7.82M
--3.77M
----
----
--0
--0
Other current liabilities
2.55%2.74M
2.49%2.72M
-0.18%2.7M
2.09%2.68M
2.09%2.68M
21.12%2.67M
20.39%2.65M
22.84%2.71M
19.35%2.63M
19.35%2.63M
Current liabilities
36.22%25.63M
71.15%26.84M
7.14%21.51M
2.08%31.6M
2.08%31.6M
-31.13%18.82M
-31.31%15.68M
9.98%20.08M
41.09%30.95M
41.09%30.95M
Non current liabilities
Non current deferred liabilities
-17.42%17.49M
--18.22M
--19.21M
--20.04M
--20.04M
5,671.66%21.18M
----
----
--0
--0
Other non current liabilities
0.54%12.31M
6.78%12.35M
11.17%13.31M
41.68%13.14M
41.68%13.14M
-64.34%12.25M
-64.63%11.57M
-65.07%11.97M
-73.25%9.27M
-73.25%9.27M
Total non current liabilities
-10.84%29.8M
164.28%30.57M
171.61%32.51M
257.74%33.18M
257.74%33.18M
-3.67%33.43M
-65.02%11.57M
-65.44%11.97M
-73.53%9.27M
-73.53%9.27M
Total liabilities
6.11%55.43M
110.68%57.41M
68.57%54.03M
61.02%64.77M
61.02%64.77M
-15.77%52.24M
-51.25%27.25M
-39.41%32.05M
-29.40%40.23M
-29.40%40.23M
Shareholders'equity
Share capital
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
-common stock
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-17.57%-947.99M
-16.86%-933.38M
-16.53%-917.95M
-17.13%-902.86M
-17.13%-902.86M
-4.81%-806.31M
-7.93%-798.72M
-10.87%-787.74M
-12.97%-770.8M
-12.97%-770.8M
Paid-in capital
14.04%1.07B
14.11%1.06B
14.13%1.06B
14.03%1.06B
14.03%1.06B
1.00%936.03M
1.31%933.01M
4.79%930.11M
5.36%928.08M
5.36%928.08M
Gains losses not affecting retained earnings
39.81%597K
204.10%482K
219.23%434K
191.51%97K
191.51%97K
137.82%427K
58.33%-463K
-2.82%-364K
88.18%-106K
88.18%-106K
Total stockholders'equity
-7.72%120.1M
-1.56%131.74M
1.44%144.07M
-1.03%155.55M
-1.03%155.55M
-16.75%130.15M
-25.55%133.82M
-19.68%142.01M
-20.46%157.18M
-20.46%157.18M
Total equity
-7.72%120.1M
-1.56%131.74M
1.44%144.07M
-1.03%155.55M
-1.03%155.55M
-16.75%130.15M
-25.55%133.82M
-19.68%142.01M
-20.46%157.18M
-20.46%157.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -24.91%95.91M-10.16%99.81M-17.83%105.31M-4.63%113.59M-4.63%113.59M23.94%127.72M-7.25%111.09M-24.96%128.17M-45.26%119.11M-45.26%119.11M
-Cash and cash equivalents -47.00%25.26M11.25%25.4M-15.30%30.36M-38.39%24.57M-38.39%24.57M22.06%47.65M-26.70%22.83M-19.86%35.84M-11.92%39.88M-11.92%39.88M
-Short-term investments -11.76%70.66M-15.70%74.4M-18.81%74.96M12.36%89.02M12.36%89.02M25.09%80.07M-0.41%88.26M-26.77%92.33M-54.02%79.23M-54.02%79.23M
Receivables 1,264.43%4.68M-40.31%194K-32.98%250K6.71%318K6.71%318K-0.87%343K-24.59%325K-45.63%373K-38.43%298K-38.43%298K
-Accounts receivable 1,264.43%4.68M-40.31%194K-32.98%250K6.71%318K6.71%318K-0.87%343K-24.59%325K-45.63%373K-38.43%298K-38.43%298K
Other current assets -----32.41%4.2M-52.55%3.23M27.37%12.04M27.37%12.04M-78.32%4.27M-51.16%6.22M-47.18%6.8M-29.96%9.45M-29.96%9.45M
Total current assets -23.98%100.59M-11.42%104.2M-19.62%108.79M-2.25%125.95M-2.25%125.95M7.53%132.33M-11.51%117.64M-26.59%135.34M-44.35%128.86M-44.35%128.86M
Non current assets
Net PPE -28.42%811K-32.87%868K-38.47%942K-37.78%1.01M-37.78%1.01M-35.77%1.13M-31.91%1.29M1.19%1.53M47.41%1.62M47.41%1.62M
-Gross PPE -0.31%5.8M1.12%5.88M-0.24%5.86M0.54%5.81M0.54%5.81M-8.72%5.81M-7.85%5.81M2.55%5.87M12.62%5.78M12.62%5.78M
-Accumulated depreciation -6.50%-4.98M-10.84%-5.01M-13.25%-4.91M-15.45%-4.81M-15.45%-4.81M-1.65%-4.68M-2.52%-4.52M-3.04%-4.34M-3.15%-4.16M-3.15%-4.16M
Investments and advances 55.96%71.3M109.10%81.08M156.67%85.21M43.86%90.3M43.86%90.3M-45.54%45.71M-57.38%38.78M-1.20%33.2M412.75%62.77M412.75%62.77M
Other non current assets -11.91%2.83M-11.05%2.99M-21.17%3.15M-26.26%3.07M-26.26%3.07M20.89%3.22M16.52%3.37M22.05%4M52.20%4.16M52.20%4.16M
Total non current assets 49.69%74.94M95.56%84.95M130.60%89.3M37.68%94.38M37.68%94.38M-47.46%50.06M-57.71%43.44M-14.59%38.73M197.44%68.55M197.44%68.55M
Total assets -3.76%175.53M17.43%189.15M13.80%198.09M11.61%220.33M11.61%220.33M-16.47%182.39M-31.65%161.07M-24.22%174.07M-22.46%197.41M-22.46%197.41M
Liabilities
Current liabilities
Payables 19.90%9.19M21.02%8.8M-41.22%6.35M-47.17%4.69M-47.17%4.69M-20.58%7.66M-36.38%7.27M31.99%10.81M-14.23%8.88M-14.23%8.88M
-accounts payable 19.90%9.19M21.02%8.8M-41.22%6.35M-47.17%4.69M-47.17%4.69M-20.58%7.66M-36.38%7.27M31.99%10.81M-14.23%8.88M-14.23%8.88M
Current accrued expenses 72.53%3.66M-10.18%3.26M-23.12%3.75M-26.45%11.43M-26.45%11.43M-79.21%2.12M-25.11%3.62M5.23%4.87M356.14%15.54M356.14%15.54M
Current deferred liabilities 67.25%6.3M--9.33M--6.98M--7.82M--7.82M--3.77M----------0--0
Other current liabilities 2.55%2.74M2.49%2.72M-0.18%2.7M2.09%2.68M2.09%2.68M21.12%2.67M20.39%2.65M22.84%2.71M19.35%2.63M19.35%2.63M
Current liabilities 36.22%25.63M71.15%26.84M7.14%21.51M2.08%31.6M2.08%31.6M-31.13%18.82M-31.31%15.68M9.98%20.08M41.09%30.95M41.09%30.95M
Non current liabilities
Non current deferred liabilities -17.42%17.49M--18.22M--19.21M--20.04M--20.04M5,671.66%21.18M----------0--0
Other non current liabilities 0.54%12.31M6.78%12.35M11.17%13.31M41.68%13.14M41.68%13.14M-64.34%12.25M-64.63%11.57M-65.07%11.97M-73.25%9.27M-73.25%9.27M
Total non current liabilities -10.84%29.8M164.28%30.57M171.61%32.51M257.74%33.18M257.74%33.18M-3.67%33.43M-65.02%11.57M-65.44%11.97M-73.53%9.27M-73.53%9.27M
Total liabilities 6.11%55.43M110.68%57.41M68.57%54.03M61.02%64.77M61.02%64.77M-15.77%52.24M-51.25%27.25M-39.41%32.05M-29.40%40.23M-29.40%40.23M
Shareholders'equity
Share capital 0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K
-common stock 0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -17.57%-947.99M-16.86%-933.38M-16.53%-917.95M-17.13%-902.86M-17.13%-902.86M-4.81%-806.31M-7.93%-798.72M-10.87%-787.74M-12.97%-770.8M-12.97%-770.8M
Paid-in capital 14.04%1.07B14.11%1.06B14.13%1.06B14.03%1.06B14.03%1.06B1.00%936.03M1.31%933.01M4.79%930.11M5.36%928.08M5.36%928.08M
Gains losses not affecting retained earnings 39.81%597K204.10%482K219.23%434K191.51%97K191.51%97K137.82%427K58.33%-463K-2.82%-364K88.18%-106K88.18%-106K
Total stockholders'equity -7.72%120.1M-1.56%131.74M1.44%144.07M-1.03%155.55M-1.03%155.55M-16.75%130.15M-25.55%133.82M-19.68%142.01M-20.46%157.18M-20.46%157.18M
Total equity -7.72%120.1M-1.56%131.74M1.44%144.07M-1.03%155.55M-1.03%155.55M-16.75%130.15M-25.55%133.82M-19.68%142.01M-20.46%157.18M-20.46%157.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 +2.63%
Sample Name
Sample Code
 +2.18%
4
Netflix
NFLX
+1.96%
5
Amazon
AMZN
+1.57%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +18.98%
Sample Name
Sample Code
 +8.55%
Sample Name
Sample Code
 +4.66%
4
H World Group
HTHT
+4.17%
5
KE Holdings
BEKE
+4.16%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -